Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06350539
Status:
RECRUITING
Last Update Posted:
2024-04-05
First Post:
2024-03-21
Brief Title:
Personalized Models for Cancer Research
Sponsor:
New York Stem Cell Foundation Research Institute
Organization:
New York Stem Cell Foundation Research Institute
Study Overview
Official Title:
Personalized Models for Cancer Research
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The New York Stem Cell Foundation NYSCF Research Institute is performing this research to accelerate cancer research ranging from disease mechanisms to personalized medicine approaches that will help to realize the promise of precision medicine for oncology
Detailed Description:
Researchers at the New York Stem Cell Foundation NYSCF Research Institute will establish a living biobank of tumororganoids and stem cells representing individual patients diagnosed with cancer Samples from healthy individuals non-cancer diagnosis or from non-disease tissue will also be collected to be used as controls in this study
Information and biospecimens may be transferred to NYSCF by external institution or NYSCF research personnel may prospectively enroll participants to have portions of samples or cells that were or will be collected for reasons other than this study transferred into the biobank
NYSCFs researchers hypothesize that the development of patient-specific models that can expand in vitro while capturing tumor complexity at the genotypic and phenotypic levels will enable accelerated discovery of more efficient treatments for patients and improve outcomes
This study is not a clinical trial
Information and biospecimens may be transferred to NYSCF by external institution or NYSCF research personnel may prospectively enroll participants to have portions of samples or cells that were or will be collected for reasons other than this study transferred into the biobank
NYSCFs researchers hypothesize that the development of patient-specific models that can expand in vitro while capturing tumor complexity at the genotypic and phenotypic levels will enable accelerated discovery of more efficient treatments for patients and improve outcomes
This study is not a clinical trial
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None